HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multifaceted Effects of Delta Opioid Receptors and DADLE in Diseases of the Nervous System.

AbstractBACKGROUND:
The opioid system is considered a potential therapeutic target in a variety of neurological disorders. Delta opioid receptors (DORs) are broadly expressed in the brain, and their activation protects cells from hypoxic/ischemic insults by counteracting disruptions of ionic homeostasis and initiating neuroprotective pathways. The DOR agonist D-Ala2-D-Leu2-Enkephalin (DADLE) promotes neuronal survival, mitigates apoptotic pathways, and protects neurons and glial cells from ischemia-induced cell death, thus making DADLE a promising therapeutic option for stroke. The significant amount of research regarding DORs and DADLE in the last decades also suggests their potential in treating other neurological disorders.
METHODS:
This review compiled relevant literature detailing the role of DORs and agonists in central nervous system function and neuropathologies.
RESULTS:
Several studies demonstrate potential mechanisms implicating a key interaction between DORs and DADLE in conferring neuroprotective benefits. A better understanding of DOR function in disease-specific contexts is critical to transitioning DOR agonists into the clinic as a therapy for stroke and other neurological diseases.
CONCLUSION:
Evidence-based studies support the potential of the delta-opioid family of receptors and its ligands in developing novel therapeutic strategies for stroke and other brain disorders.
AuthorsJea-Young Lee, M Grant Liska, Marci Crowley, Kaya Xu, Sandra A Acosta, Cesar V Borlongan, Vivian A Guedes
JournalCurrent drug discovery technologies (Curr Drug Discov Technol) Vol. 15 Issue 2 Pg. 94-108 ( 2018) ISSN: 1875-6220 [Electronic] United Arab Emirates
PMID29032758 (Publication Type: Journal Article, Review)
CopyrightCopyright© Bentham Science Publishers; For any queries, please email at [email protected].
Chemical References
  • Analgesics, Opioid
  • Receptors, Opioid, delta
  • Enkephalin, Leucine-2-Alanine
Topics
  • Analgesics, Opioid (metabolism, pharmacology, therapeutic use)
  • Animals
  • Enkephalin, Leucine-2-Alanine (metabolism, pharmacology, therapeutic use)
  • Humans
  • Nervous System Diseases (drug therapy, metabolism)
  • Receptors, Opioid, delta (agonists, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: